SB 758 adds two new state offenses aimed at reducing access to two substances regulators associate with misuse. The bill inserts Section 22984 into the Business and Professions Code to bar retailers from selling nitrous oxide (as defined in Penal Code section 381c) at retail locations, while expressly excluding grocery stores and general retail merchants with grocery departments from that prohibition.
It also adds Section 11364.1 to the Health and Safety Code to make the sale or distribution of products containing 7‑hydroxymitragynine a misdemeanor, but expressly exempts the compound when it exists naturally within the plant Mitragyna speciosa.
The package matters because it moves two product controls into the criminal code rather than an administrative enforcement regime. That shift creates immediate compliance questions for tobacco and specialty retailers, distributors, and manufacturers, and it raises practical issues for prosecutors, public health officials, and laboratories about how to identify covered products and enforce the new prohibitions.
At a Glance
What It Does
SB 758 adds B&P Code §22984 to prohibit sale of nitrous oxide at retail locations (referencing Penal Code §381c) while carving out grocery stores and general retail merchants with grocery departments. It also adds H&S Code §11364.1 to criminalize sale or distribution of products containing 7‑hydroxymitragynine except when present naturally in Mitragyna speciosa.
Who It Affects
Primary targets are tobacco and specialty retailers, convenience stores, party-supply and smoke shops, manufacturers and distributors of botanical extracts and novel psychoactive products, and local prosecutors and courts that will handle misdemeanor prosecutions. Grocery chains keep an express exemption, so distribution channels and purchasers will see market shifts.
Why It Matters
The bill establishes criminal penalties instead of administrative sanctions and does not set testing, labeling, or inspection protocols, meaning enforcement depends on prosecutors and laboratory proof. Businesses that sell consumer products with botanical extracts or nitrous oxide chargers will need to reassess inventories and supply contracts quickly to avoid criminal exposure.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 758 tackles two separate substance‑control problems with statutory bans. For nitrous oxide, the bill bars ‘‘retailers’’ from selling the gas at retail locations.
The text points to the Penal Code definition of nitrous oxide, but it also narrows the scope of who counts as a ‘‘retailer’’ for this rule: full grocery stores and general retail establishments that include a grocery department remain outside the ban. The practical result is a storefront prohibition that will require non‑grocery retailers to remove whipped‑cream chargers and other consumer nitrous oxide products from shelves, while some mainstream supermarkets can continue sales.
On the botanical side, the bill makes it a misdemeanor to sell or distribute any product containing 7‑hydroxymitragynine unless that compound is present only as it occurs naturally within the plant Mitragyna speciosa (commonly called kratom). That language singles out chemically concentrated or synthesized forms of a mitragynine metabolite while leaving whole‑plant kratom untouched.
The statute criminalizes distribution and sale but does not create a parallel civil‑regulatory regime—no labeling standards, testing protocols, or administrative recall mechanism appear in the text.Because both prohibitions are cast as misdemeanors, enforcement will typically proceed through local prosecutors and the courts rather than an administrative licensing board. The bill also contains a fiscal clause stating no state reimbursement to local governments is required because the act creates new crimes—meaning local law enforcement and judicial systems will carry the immediate fiscal and operational burdens of implementation.
Practically, affected businesses should expect to revise purchasing contracts, remove covered products from store shelves or online listings, and seek supplier documentation; public health and law enforcement agencies will need to develop laboratory testing protocols and charging standards for 7‑hydroxymitragynine cases.Finally, the law leaves open several gaps that matter on the ground: it does not expressly regulate online sales or cross‑border shipments, it does not prescribe analytical thresholds for measuring 7‑hydroxymitragynine in products, and it creates an explicit exemption for certain retail formats that could shift where consumers purchase restricted items. Those drafting and enforcement details will determine how far the statute changes market behavior versus simply moving sales to different channels.
The Five Things You Need to Know
B&P Code §22984: the bill makes selling nitrous oxide at a ‘‘retail location’’ a prohibited act and references Penal Code §381c for the definition of nitrous oxide.
The statute explicitly excludes grocery stores and general retail merchandise stores with grocery departments (Civil Code §7100) from the nitrous‑oxide ban, creating a carved‑out distribution channel.
H&S Code §11364.1 makes selling or distributing any product that contains 7‑hydroxymitragynine a misdemeanor, but it exempts the compound when it appears naturally in the Mitragyna speciosa plant.
SB 758 adds two new criminal offenses rather than administrative penalties and contains a clause stating no state reimbursement is required for local costs because the act creates new crimes.
The bill does not set testing standards, labeling rules, inspection authority, or explicit controls on online sales, so proving violations will rely on laboratory evidence and criminal prosecutions rather than administrative enforcement.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Retail sales ban on nitrous oxide
This provision forbids ‘‘a retailer’’ from selling nitrous oxide at a retail location and ties the meaning of nitrous oxide to Penal Code §381c. Crucially, it narrows the definition of ‘‘retailer’’ for this ban by excluding grocery stores and general retail merchandise stores with grocery departments as defined in Civil Code §7100. The immediate practical effect is a storefront prohibition that applies to convenience stores, tobacco vendors, party‑supply shops and other non‑grocery retailers; the statute itself does not create new licensing sanctions, inspection authority, or a civil penalty scheme tied to the state’s existing tobacco licensing program.
Misdemeanor for products with 7‑hydroxymitragynine
This section criminalizes the sale or distribution of any product that contains 7‑hydroxymitragynine unless the compound exists only as it naturally occurs in Mitragyna speciosa. The text targets concentrated, processed, or synthetic forms of this alkaloid while leaving whole‑plant kratom products untouched in theory. Enforcement will require chemical analysis to establish presence and concentration; the statute provides no analytical threshold, chain‑of‑custody protocol, or administrative recalls, meaning proof of a violation will rest on criminal evidence standards and laboratory work.
No state reimbursement; local enforcement burden
The bill expressly states that no reimbursement to local agencies is required under Article XIII B because the act creates new crimes or changes the definition of crimes, citing Government Code §17556. That language signals the Legislature’s view that local law enforcement and courts will absorb enforcement costs. For local governments, that means staffing, lab testing, prosecution, and court processing costs are foreseeable outlays without a specified state funding stream.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Local public‑health programs and youth health advocates — a clearer statutory tool to argue for reduced retail access to inhalants and concentrated mitragynine derivatives, potentially reducing exposures that lead to emergency department visits.
- Grocery chains and supermarkets — they retain an express exemption and therefore a competitive advantage for selling nitrous oxide‑containing products over other retail formats.
- Public safety officials and prosecutors who prioritize substance‑related offenses — the bill gives them misdemeanor charges to use where they deem appropriate, rather than relying on administrative remedies or civil enforcement.
Who Bears the Cost
- Convenience stores, tobacco and vape shops, party‑supply stores and other non‑grocery retailers — they must remove nitrous oxide products from retail shelves or risk misdemeanor exposure, losing a source of impulse sales.
- Manufacturers, importers, and distributors of concentrated or synthetic 7‑hydroxymitragynine extracts — they face criminal liability for sales and may need to reformulate, relabel, or withdraw products from California markets.
- Local law enforcement and county prosecutors — they absorb investigative, laboratory, and prosecution costs for misdemeanors without a designated state reimbursement stream.
- Online marketplaces and out‑of‑state sellers — while not explicitly regulated, they will face increased compliance pressure and potential enforcement actions tied to shipments into California, creating legal and logistical burdens.
Key Issues
The Core Tension
The central dilemma is whether to reduce access to substances linked to misuse by criminalizing sales—shifting responsibility to prosecutors and courts—or to pursue administrative regulation that can set testing, labeling and licensing rules; SB 758 opts for criminal law, which can deter supply quickly but creates enforcement, scientific‑proof, and equity challenges without providing administrative tools or funding to manage them.
The bill sets bright‑line criminal rules but leaves the hard implementation questions unanswered. For 7‑hydroxymitragynine, courts and prosecutors will need reliable laboratory methods and agreed‑upon analytical thresholds to prove a product ‘‘contains’’ the compound; absent those standards, defense challenges on chain of custody, method validation, and concentration thresholds are likely.
The ‘‘except as it naturally occurs’’ carve‑out for Mitragyna speciosa is conceptually tidy but technically messy: many commercial kratom products are extracts or blends where the line between ‘‘natural occurrence’’ and concentrated presence is ambiguous. Determining whether a product falls inside the exemption will require forensic chemistry and probably litigation to set precedents.
The nitrous‑oxide ban introduces distributional quirks that could blunt its public‑health intent or simply change market geography. Exempting grocery stores creates a predictable displacement: consumers can still buy chargers in supermarkets but not at convenience stores, which concentrates sales into certain outlets and may incentivize online purchases or informal channels.
The statute also leaves online and mail‑order sales unaddressed, creating enforcement gaps. Finally, criminalizing sales rather than creating an administrative enforcement pathway elevates the role of prosecutorial discretion and risks uneven enforcement across jurisdictions; places with limited lab capacity or strained public‑safety budgets will see different practical impacts than better‑resourced counties.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.